The observation of monoallelic inactivation of the CDKN1B gene alteration in several tumors, including si-NET, breast cancers, and parathyroid adenomas, suggests that CDKN1B might be considered a haploinsufficient tumor suppressor. Here, CDKN1B is linked to breast carcinoma.